Resistant and panresistant A. baumanni infection in ICU

M. Balci Kalamanogu, N. Adigüzel, Z. Karakurt, O. Yazicioglu Moçin, E. Acartürk, C. Saltürk, G. Güngör, M. Partal, S. Batikulu, A. Yilmaz (Istanbul, Turkey)

Source: Annual Congress 2010 - Intensive care unit outcome
Session: Intensive care unit outcome
Session type: Thematic Poster Session
Number: 2270
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Balci Kalamanogu, N. Adigüzel, Z. Karakurt, O. Yazicioglu Moçin, E. Acartürk, C. Saltürk, G. Güngör, M. Partal, S. Batikulu, A. Yilmaz (Istanbul, Turkey). Resistant and panresistant A. baumanni infection in ICU. Eur Respir J 2010; 36: Suppl. 54, 2270

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003

Community-acquired pneumonia due to multidrug and non-multidrug resistant pseudomonas aeruginosa
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Acinetobacter baumanii as a severity marker in a respiratory ICU
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006

Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Source: Eur Respir J 2007; 29: 548-560
Year: 2007



Potential treatment for nosocomial respiratory strains of extreme drug resistant acinetobacter baumanii
Source: Eur Respir J 2007; 30: Suppl. 51, 410s
Year: 2007

Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience
Source: Eur Respir J 2005; 26: Suppl. 49, 222s
Year: 2005

Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018

The mortality of Acinetobacter baumanni infection in intensive care unit
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012

Antibiotic sensitivity of pseudomonas aeroginosa isolates of respiratory secretions taken from ICU patients of the NRITLD
Source: Eur Respir J 2004; 24: Suppl. 48, 641s
Year: 2004

Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010



Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017

Association of acinetobacter baumannii respiratory isolates with hospital outcomes in ventilated patients
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006

Inhaled colistin on Acinetobacter baumannii treatment
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012


Activity of N-acetylcysteine in combination with colistin against a collection of colistin resistant Acinetobacter baumannii clinical isolates
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017


Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Multidrug-resistant bacteria in community-acquired pneumonia
Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Year: 2017


Direct LAMP assay from clinical sample for carbapenem resistant A. baumannii
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Multidrug resistant acinetobacter baumannii in ventilator associated pneumonia: Prevalence and predictors of mortality
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014